Skip to main content

Advertisement

Articles

Page 5 of 7

  1. The use of subgroups based on biological-clinical and socio-demographic variables to deal with population heterogeneity is well-established in public policy. The use of subgroups based on preferences is rare, ...

    Authors: Mette Kjer Kaltoft, Robin Turner, Michelle Cunich, Glenn Salkeld, Jesper Bo Nielsen and Jack Dowie

    Citation: Health Economics Review 2015 5:10

    Content type: Research

    Published on:

  2. This article examines young people's preferences for integrated family planning (FP) and HIV services in rural Malawi. Different hypothetical configurations for outreach services are presented using a Discrete...

    Authors: Christine Michaels-Igbokwe, Mylene Lagarde, John Cairns and Fern Terris-Prestholt

    Citation: Health Economics Review 2015 5:9

    Content type: Research

    Published on:

  3. Decision-analytic modelling (DAM) has become a widespread method in health technology assessments (HTA), but the extent to which modelling is used differs among international HTA institutions. In Germany, the ...

    Authors: Alexander Kuhlmann, Marina Treskova, Sebastian Braun and J-Matthias Graf von der Schulenburg

    Citation: Health Economics Review 2015 5:7

    Content type: Research

    Published on:

  4. Heavy episodic (“binge”) drinking of alcohol has serious public health implications, especially for youth and young adults. Previous summaries and surveys have failed to address in a comprehensive manner the e...

    Authors: Jon P Nelson

    Citation: Health Economics Review 2015 5:6

    Content type: Review

    Published on:

    The Letter to Editor to this article has been published in Health Economics Review 2016 6:4

  5. Recently, Nigeria emerged as the largest economy in Africa and the 26th in the world. However, a pertinent question is how this new economic status has impacted on the wealth and health of her citizens. There ...

    Authors: Adeniyi F Fagbamigbe, Elijah A Bamgboye, Bidemi O Yusuf, Joshua O Akinyemi, Bolakale K Issa, Evelyn Ngige, Perpetua Amida, Adebobola Bashorun and Emmanuel Abatta

    Citation: Health Economics Review 2015 5:5

    Content type: Research

    Published on:

  6. The medical record is a repository of clinical data, which can greatly enhance the quality of health and healthcare analysis. Administrative data are collected for the purpose of billing and reimbursement, and...

    Authors: David Rowell, Louisa G Gordon, Catherine M Olsen and David C Whiteman

    Citation: Health Economics Review 2015 5:4

    Content type: Research

    Published on:

  7. South-East Asian Regional (SEAR) countries range from low- to middle-income countries and have considerable differences in mix of public and private sector expenditure on health. This study intends to estimate...

    Authors: Jahangir AM Khan and Rashidul Alam Mahumud

    Citation: Health Economics Review 2015 5:3

    Content type: Research

    Published on:

  8. This article aims to assess the relationship between the monetary value of informal care - approximated with the caregiver's willingness to pay to reduce caregiving time - and the caregiver's need of three typ...

    Authors: Chloé Gervès-Pinquié, Martine M Bellanger and Joel Ankri

    Citation: Health Economics Review 2014 4:34

    Content type: Research

    Published on:

  9. Early benefit assessment in Germany under the legislative framework of AMNOG (Arzneimittelmarktneuordnungsgesetz) requires direct comparisons of the new drug with appropriate comparators determined by the Federal...

    Authors: Andrea Lebioda, David Gasche, Franz-Werner Dippel, Karlheinz Theobald and Stefan Plantör

    Citation: Health Economics Review 2014 4:31

    Content type: Research

    Published on:

  10. To obtain detailed real-world data on persistence and dosing patterns in the utilisation of the TNF inhibitors adalimumab, etanercept, and infliximab in rheumatoid arthritis (RA) patients treated in Germany.

    Authors: Sarah Neubauer, Mary Cifaldi, Thomas Mittendorf, Arijit Ganguli, Malte Wolff and Jan Zeidler

    Citation: Health Economics Review 2014 4:32

    Content type: Research

    Published on:

  11. EQ-5D-3L valuation studies continue to employ the MVH protocol or variants of MVH. One issue that has received attention is the selection of the states for direct valuation by respondents. Changes in the valua...

    Authors: Henry Bailey, Paul Kind and Althea La Foucade

    Citation: Health Economics Review 2014 4:29

    Content type: Research

    Published on:

  12. Diabetes Mellitus Type II (T2DM) is a major and growing medical, social and economic burden in the East-Asian country of Cambodia. However, no economic modelling has been done to predict the number of cases an...

    Authors: Steffen Flessa and Anika Zembok

    Citation: Health Economics Review 2014 4:24

    Content type: Research

    Published on:

  13. The aim of this study is to estimate the cost of care and treatment for extremely low birth weight (ELBW) neonates admitted to a teaching and referral hospital. This cost estimation project can help health pol...

    Authors: Hosein Dalili, Mohaddese Fallahi, Saeid Moradi, Fatemeh Nayeri, Mamak Shariat and Arash Rashidian

    Citation: Health Economics Review 2014 4:21

    Content type: Research

    Published on:

  14. The introduction of the European Working Time Directive (EWTD) has greatly reduced training hours of surgical residents, which translates into 30% less surgical and clinical experience. Such a dramatic drop in...

    Authors: Simon Schimmack, Ulf Hinz, Andreas Wagner, Thomas Schmidt, Hendrik Strothmann, Markus W Büchler and Hubertus Schmitz-Winnenthal

    Citation: Health Economics Review 2014 4:14

    Content type: Research

    Published on:

  15. To assess the impact of reference pricing and extension of generic substitution on the daily cost of antipsychotic drugs in Finland during the first year after its launch. Furthermore, the additional impact of...

    Authors: Hanna Koskinen, Elina Ahola, Leena K Saastamoinen, Hennamari Mikkola and Jaana E Martikainen

    Citation: Health Economics Review 2014 4:9

    Content type: Research

    Published on:

  16. In Switzerland, age is the predominant driver of solidarity transfers in risk adjustment (RA). Concerns have been voiced regarding growing imbalances in cost sharing between young and old insured due to demogr...

    Authors: Viktor von Wyl and Konstantin Beck

    Citation: Health Economics Review 2014 4:7

    Content type: Research

    Published on:

  17. While induced abortion is considered to be illegal and socially unacceptable in Nigeria, it is still practiced by many women in the country. Poor family planning and unsafe abortion practices have daunting eff...

    Authors: Bosede O Awoyemi and Jacob Novignon

    Citation: Health Economics Review 2014 4:3

    Content type: Research

    Published on:

  18. To identify associations between market factors, especially relative reimbursement rates, and the probability of surgery and cost per episode for three medical conditions (cataract, benign prostatic neoplasm, ...

    Authors: Jack Hadley, James D Reschovsky, James A O’Malley and Bruce E Landon

    Citation: Health Economics Review 2014 4:8

    Content type: Research

    Published on:

  19. In the majority of children and adolescents with epilepsy, optimal drug therapy adequately controls their condition. However, among the remaining patients who are still uncontrolled despite mono-, bi- or tri-t...

    Authors: Dawn C Lee, Daniel Gladwell, Anthony J Hatswell, Joshua Porter, Nic Brereton, Elaine Tate and Alison L Saunders

    Citation: Health Economics Review 2014 4:6

    Content type: Research

    Published on:

  20. The prospective reimbursement of hospitals through the grouping of patients into a finite number of categories (Diagnosis Related Groups, DRGs), is common to many European countries. However, the specific cate...

    Authors: James Gaughan and Conrad Kobel

    Citation: Health Economics Review 2014 4:4

    Content type: Research

    Published on:

  21. The German AMNOG healthcare reform includes a mandatory early-benefit-assessment (EBA) at launch. As per German social code, EBA is based on registration trials and includes evaluation of the patient-relevant ...

    Authors: Inna Dabisch, Jürgen Dethling, Charalabos-Markos Dintsios, Melanie Drechsler, Daniel Kalanovic, Peter Kaskel, Frank Langer, Jörg Ruof, Thorsten Ruppert and Daniel Wirth

    Citation: Health Economics Review 2014 4:2

    Content type: Review

    Published on:

  22. Care of stroke patients costs considerably more in specialized stroke units (SU) compared to care in general medical wards (GMW) but the technology may be cost effective if it leads to significantly improved o...

    Authors: Farasat AS Bokhari, Ian Wellwood, Anthony G Rudd, Peter Langhorne, Martin S Dennis and Charles DA Wolfe

    Citation: Health Economics Review 2014 4:1

    Content type: Research

    Published on:

  23. In April 2008, specialization in gynecology and obstetrics departments was introduced in the Sennan area of Osaka prefecture in Japan that aimed at solving the problems of regional provisions of obstetrics ser...

    Authors: Yoshimi Adachi, Hiroyasu Iso, Junyi Shen, Kanami Ban, On Fukui, Hiroyuki Hashimoto, Takako Nakashima, Kenichiro Morishige and Tatuyoshi Saijo

    Citation: Health Economics Review 2013 3:31

    Content type: Research

    Published on:

  24. Patient-centered health care and shared decision making are of increasing importance in the management of AIDS/HIV patients and require an intensive consideration of patient preferences. The present study asse...

    Authors: Axel C Mühlbacher, Matthias Stoll, Jörg Mahlich and Matthias Nübling

    Citation: Health Economics Review 2013 3:30

    Content type: Research

    Published on:

  25. Recently the sequencing of the human genome has become a major biological and clinical research field. However, the public health impact of this new technology with focus on the financial effect is not yet to ...

    Authors: Martin Frank, Anne Prenzler, Roland Eils and J-Matthias Graf von der Schulenburg

    Citation: Health Economics Review 2013 3:29

    Content type: Review

    Published on:

  26. The objective of the study was to analyse whether azacitidine is a cost-effective option for the treatment of myelodysplastic syndrome in the Spanish setting compared with conventional care regimens, including...

    Authors: Carlos Crespo, Estela Moreno, Jordi Sierra, Suzan Serip and Marta Rubio

    Citation: Health Economics Review 2013 3:28

    Content type: Research

    Published on:

Annual Journal Metrics

Advertisement